ArticleJACC. Advances2026
Trends in the Co-Occurrence of Alcohol Use and Cardiovascular Disease Among U.S. Adults, 1999 to 2023.
Article in JACC. Advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlcohol use and cardiovascular disease (CVD) are major public health concerns, but their co-occurrence over time remains unclear.
objectivesThe objective of the study was to examine trends in the co-occurrence of alcohol use and CVD among U.S. adults.
methodsWe analyzed 43,465 U.S. adults from 11 cycles of the National Health and Nutrition Examination Survey (1999-2023). Alcohol use was categorized as no drinking (0 drinks/week), low-to-moderate drinking (≤7 drinks/week for women; ≤14 for men), and heavy drinking (>7 for women; >14 for men). Joinpoint regression estimated trends in co-occurrence of alcohol use and overall and type-specific CVD, stratified by age, sex, race/ethnicity, poverty-income ratio and educational attainment. Trends were quantified using annual percentage change (APC).
resultsAmong 43,465 adults, 5,180 had CVD. The prevalence of heavy drinking among those with CVD increased from 17.1% in 1999 to 2000 to 33.4% in 2021 to 2023, whereas the prevalence of nondrinkers and low-to-moderate drinkers among participants with CVD declined. In overall population, the prevalence of co-occurrence of heavy drinking and CVD increased from 1.4% to 3.0% (APC: 3.4%; 95% CI: 2.0%-5.1%). Increases appeared more pronounced in adults aged 40 to 59 years (post-2007), women, non-Hispanic Whites, and those with lower poverty-income ratio or educational attainment. The co-occurrence of heavy drinking with heart failure (APC: 3.8%), angina (1.7%), and stroke (5.2%) increased. In contrast, nondrinking with CVD declined (-1.4%), and low-to-moderate drinking with CVD remained stable.
conclusionsFrom 1999 to 2023, the co-occurrence of heavy alcohol use and CVD increased substantially, especially among certain demographic groups.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.